Related Experiment Videos
Microalbuminuria in type 2 diabetics: an important, overlooked cardiovascular risk factor
1Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201-1595, USA. mweir@medicine.umaryland.edu
Abstract:
The presence of microalbumin in the urine of persons with type 2 diabetes is perhaps the most important early signal heralding the onset of systemic vasculopathy and associated target organ damage to the brain, the heart, and the kidneys. It is easily measured and, unfortunately, frequently overlooked as a screening tool in clinical medicine. If present, it identifies patients at risk for early cardiovascular death and progressive renal disease. Microalbuminuria also identifies patients who need more rigorous cardiovascular risk management, especially more intensive blood pressure control, preferably below 130/80 mm Hg, and strict attention to glycemic control and lipid levels. Therapeutic strategies to facilitate better blood pressure control and reduce microalbuminuria likely will prove to be the most effective way to retard not only the progression of renal disease but also cardiovascular disease. Consequently, the identification and normalization of urine microalbumin excretion should be an important consideration in patients with diabetes.
Insights
Microalbuminuria in type 2 diabetes signals early vasculopathy and organ damage. Early detection and management, including blood pressure control, can reduce cardiovascular and renal disease progression.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Microalbuminuria is a critical early indicator of systemic vasculopathy in type 2 diabetes.
- It signifies potential damage to vital organs like the brain, heart, and kidneys.
- This marker is often underutilized in routine clinical screening.
Purpose of the Study:
- To emphasize the significance of microalbuminuria as an early warning sign in type 2 diabetes.
- To highlight its role in identifying patients at high risk for cardiovascular and renal complications.
- To advocate for improved screening and management strategies.
Main Methods:
- Urine microalbumin measurement as a screening tool.
- Risk assessment for cardiovascular events and renal disease progression.
- Evaluation of therapeutic strategies for blood pressure, glycemic, and lipid control.
Main Results:
- Presence of microalbuminuria identifies patients at increased risk of early cardiovascular death.
- It predicts progressive renal disease in individuals with type 2 diabetes.
- Microalbuminuria indicates the need for intensified cardiovascular risk management.
Conclusions:
- Identifying and normalizing microalbuminuria is crucial for managing type 2 diabetes.
- Effective blood pressure control (below 130/80 mm Hg) and glycemic/lipid management are vital.
- Therapeutic interventions targeting microalbuminuria can retard both renal and cardiovascular disease progression.
Related Concept Videos
Diabetic Nephropathy
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetic Retinopathy
Type II Diabetes II: Pathophysiology